| Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... Circulation 127 (1), 143-152, 2013 | 14039* | 2013 |
| Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... Circulation 131 (4), 434-441, 2015 | 12349* | 2015 |
| ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology … DP Zipes, AJ Camm, M Borggrefe, AE Buxton, B Chaitman, M Fromer, ... Journal of the American College of Cardiology 48 (5), e247-e346, 2006 | 4299* | 2006 |
| Heart disease and stroke statistics-2018 update: a report from the American Heart Association. EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ... Circulation 137 (12), e67, 2018 | 1999 | 2018 |
| Drug-induced prolongation of the QT interval DM Roden New England Journal of Medicine 350 (10), 1013-1022, 2004 | 1853 | 2004 |
| Dual-chamber pacing-or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial BL Wilkoff, JR Cook, AE Epstein, L Greene, AP Hallstrom, H Hsia, ... Journal of the American Medical Association 288 (24), 3115-3123, 2002 | 1733 | 2002 |
| American Heart Association statistics committee and stroke statistics subcommittee EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... Heart disease and stroke statistics-2017 update: a report from the American …, 2017 | 1631* | 2017 |
| The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. RB Kim, MF Fromm, C Wandel, B Leake, AJ Wood, DM Roden, ... The Journal of clinical investigation 101 (2), 289-294, 1998 | 1203 | 1998 |
| A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators New England Journal of Medicine 337 (22), 1576-1584, 1997 | 995 | 1997 |
| Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction Cardiac Arrhythmia Suppression Trial II Investigators* New England Journal of Medicine 327 (4), 227-233, 1992 | 883 | 1992 |
| Taking the “idio” out of “idiosyncratic”: predicting torsades de pointes DM Roden Pacing and Clinical Electrophysiology 21 (5), 1029-1034, 1998 | 700 | 1998 |
| Long-QT syndrome DM Roden New England Journal of Medicine 358 (2), 169-176, 2008 | 675* | 2008 |
| Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions DM Roden, R Lazzara, M Rosen, PJ Schwartz, J Towbin, GM Vincent Circulation 94 (8), 1996-2012, 1996 | 675 | 1996 |
| Genetic determinants of response to warfarin during initial anticoagulation UI Schwarz, MD Ritchie, Y Bradford, C Li, SM Dudek, A Frye-Anderson, ... New England Journal of Medicine 358 (10), 999-1008, 2008 | 671 | 2008 |
| Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes P Yang, H Kanki, B Drolet, T Yang, J Wei, PC Viswanathan, SH Hohnloser, ... Circulation 105 (16), 1943-1948, 2002 | 591 | 2002 |
| Development of a large‐scale de‐identified DNA biobank to enable personalized medicine DM Roden, JM Pulley, MA Basford, GR Bernard, EW Clayton, JR Balser, ... Clinical Pharmacology & Therapeutics 84 (3), 362-369, 2008 | 589 | 2008 |
| PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations JC Denny, MD Ritchie, MA Basford, JM Pulley, L Bastarache, ... Bioinformatics 26 (9), 1205-1210, 2010 | 585 | 2010 |
| Fulminant myocarditis with combination immune checkpoint blockade DB Johnson, JM Balko, ML Compton, S Chalkias, J Gorham, Y Xu, ... New England Journal of Medicine 375 (18), 1749-1755, 2016 | 581 | 2016 |
| A common polymorphism associated with antibiotic-induced cardiac arrhythmia F Sesti, GW Abbott, J Wei, KT Murray, S Saksena, PJ Schwartz, SG Priori, ... Proceedings of the National Academy of Sciences 97 (19), 10613-10618, 2000 | 565 | 2000 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update SA Scott, K Sangkuhl, CM Stein, JS Hulot, JL Mega, DM Roden, TE Klein, ... Clinical Pharmacology & Therapeutics 94 (3), 317-323, 2013 | 555 | 2013 |
